Search results
Results From The WOW.Com Content Network
Type 3 diabetes is a proposed pathological linkage between Alzheimer's disease and certain features of type 1 and type 2 diabetes. [1] Specifically, the term refers to a set of common biochemical and metabolic features seen in the brain in Alzheimer's disease, and in other tissues in diabetes; [1] [2] it may thus be considered a "brain-specific type of diabetes."
The researchers found that the people in the study who ate at least two servings per week of processed red meat (such as bacon, bologna or hot dogs) had a 14% increased risk of dementia, compared ...
The biomarkers can be used to diagnose Alzheimer's disease (AD) in a very early stage, but they also provide objective and reliable measures of disease progress. It is imperative to diagnose AD disease as soon as possible, because neuropathologic changes of AD precede the symptoms by years. [ 1] It is well known that amyloid beta (Aβ) is a ...
The Saint Louis University Mental Status (SLUMS) Exam is a brief screening assessment used to detect cognitive impairment. [ 1] It was developed in 2006 at the Saint Louis University School of Medicine Division of Geriatric Medicine, in affiliation with a Veterans' Affairs medical center. [ 2] The test was initially developed using a veteran ...
mheim3011/istockphoto. 3. Wandering becomes dangerous. Wandering outside of a home and getting lost is a common sign that it’s time for a memory care facility that offers security measures to ...
Noninvasive glucose monitoring ( NIGM ), called Noninvasive continuous glucose monitoring when used as a CGM technique, is the measurement of blood glucose levels, required by people with diabetes to prevent both chronic and acute complications from the disease, without drawing blood, puncturing the skin, or causing pain or trauma.
People with diabetes have a higher risk of developing serious complications including heart disease, nerve damage, kidney disease, gum disease, dementia, mood disorders, and eye problems.
assess mild cognitive impairment. The Self-administered Gerocognitive Examination is a brief cognitive assessment instrument for mild cognitive impairment (MCI) and early dementia, created by Douglas Scharre, Professor of Clinical Neurology and Psychiatry at Ohio State University Wexner Medical Center in Columbus, Ohio . A digital version exists.